Applied Nutrition Plc engages in the manufacture, wholesale, and retail of sports nutritional products in the United Kingdom and internationally. It offers whey protein, whey protein isolate, casein protein powder, clear protein, vegan protein, protein bars and oats, protein shakes and cans, and beef protein; BCAA powders and tablets, BCAA cans, creatine, aminos, and energy gels and drinks; pre-workout drinks, powders, and gels; and hydration and vitamin water, hydration tablets, hydration electrolyte and vitamin powder, and energy shots, as well as caffeine capsules and mass gainers. The company also provides products for liver support, health and vitality, vitality range, collagen, vitamins, and cooking; and gym clothing and bags, bottles and shakers, and funnels and scoops, as well as digital watches. It provides its products under the Applied Nutrition, ABE All Black Everything, BodyFuel, and Endurance brands. Applied Nutrition Plc was incorporated in 2014 and is based in Liverpool, United Kingdom.…
Applied Nutrition plc (LSE:APN) Extends Brand Reach as Product Innovation and International Expansion Support Its Sports Nutrition Momentum
Applied Nutrition (LON: APN) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 334 employees.
The shares were at 292.50 GBp on 20 November 2026, up 65.8% over 52 weeks. Its 52-week range is 169.00 GBp to 356.00 GBp: the price is 17.8% below the high and 73.1% above the low.
At a market capitalisation of 731.25M GBP, it trades at 24.4 times trailing earnings and 18.9 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, so APN is valued in line with them.
Applied Nutrition reports return on equity of 38.9%, an operating margin of 25.7% and revenue up 46.4% year over year.
It holds more cash than debt, a net cash position of 11.90M GBP. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 7 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 366.43 GBp is 25.3% above the current price.
No upcoming events tracked.